Safety and efficacy of sunitinib in patients with non-small cell lung cancer and irradiated brain metastases

被引:1
|
作者
Novello, S. [1 ]
Camps, C. [2 ]
Grossi, F. [3 ]
Mazieres, J. [4 ]
Abrey, L. [5 ]
Fain, J. [6 ]
Patyna, S. [7 ]
Selaru, P. [7 ]
Chao, R. [7 ]
Scagliotti, G. [1 ]
机构
[1] Univ Turin, Thorac Oncol Unit, Turin, Italy
[2] Univ Gen Hosp Valencia, Valencia, Spain
[3] Natl Inst Canc Res, Genoa, Italy
[4] Hop Larrey, Unite Cancerol Cervico Thorac, Toulouse, France
[5] Mem Sloan Kettering Canc Ctr, Dept Neurol, New York, NY 10021 USA
[6] Texas Oncol, Hematol Oncol, Austin, TX USA
[7] Pfizer Oncol, Dev, La Jolla, CA USA
来源
EJC SUPPLEMENTS | 2009年 / 7卷 / 02期
关键词
D O I
10.1016/S1359-6349(09)71866-X
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:551 / 551
页数:1
相关论文
共 50 条
  • [31] Activity and safety of pembrolizumab in patients with metastatic non-small cell lung cancer with untreated brain metastases.
    Goldberg, Sarah B.
    Gettinger, Scott N.
    Mahajan, Amit
    Herbst, Roy S.
    Chiang, Anne C.
    Tsiouris, A. John
    Vortmeyer, Alexander
    Jilaveanu, Lucia
    Speaker, Stephanie
    Madura, Matthew
    Rowen, Elin
    Gerrish, Heather
    Knapp-Perry, Elizabeth
    Yao, Xiaopan
    Chiang, Veronica
    Kluger, Harriet M.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [32] The Efficacy and Safety of Neoadjuvant Immunotherapy in Patients with Non-Small Cell Lung Cancer
    Guven, Deniz Can
    Sahin, Taha Koray
    Kilickap, Saadettin
    CANCERS, 2024, 16 (01)
  • [33] IMPACT OF STEROIDS ON THE EFFICACY OF IMMUNE CHECKPOINT INHIBITORS IN PATIENTS WITH NON-SMALL CELL LUNG CANCER BRAIN METASTASES
    Thapa, Bicky
    Lauko, Adam
    Borghei-Razavi, Hamid
    Suh, John
    Chao, Samuel
    Murphy, Erin
    Pennell, Nathan
    Velcheti, Vamsidhar
    Angelov, Lilyana
    Mohammadi, Alireza
    Vogelbaum, Michael
    Barnett, Gene
    Ahluwalia, Manmeet
    NEURO-ONCOLOGY, 2018, 20 : 55 - 55
  • [34] Real-Life Intracerebral Efficacy of Nivolumab in Non-Small Cell Lung Cancer Patients with Brain Metastases
    Geier, M.
    Descourt, R.
    Corre, R.
    Leveiller, G.
    Lamy, R.
    Goarant, E.
    Bizec, J.
    Bernier, C.
    Quere, G.
    Couturaud, F.
    Robinet, G.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S384 - S385
  • [35] Safety of Bevacizumab in Patients With Non-Small-Cell Lung Cancer and Brain Metastases
    Socinski, Mark A.
    Langer, Corey J.
    Huang, Jane E.
    Kolb, Margaret M.
    Compton, Peter
    Wang, Lisa
    Akerley, Wallace
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (31) : 5255 - 5261
  • [36] Survival in Patients with Non-small Cell Lung Cancer and Brain Metastases and QUARTZ in Practice
    Bradley, K. L.
    Lwin, M. T.
    Laurence, V. M.
    CLINICAL ONCOLOGY, 2010, 22 (10) : 892 - 892
  • [37] Bevacizumab for the treatment of non-small cell lung cancer patients with synchronous brain metastases
    Mustafa S. Ascha
    Jacqueline Fang Wang
    Priya Kumthekar
    Andrew E. Sloan
    Carol Kruchko
    Jill S. Barnholtz-Sloan
    Scientific Reports, 9
  • [38] Bevacizumab for the treatment of non-small cell lung cancer patients with synchronous brain metastases
    Ascha, Mustafa S.
    Wang, Jacqueline Fang
    Kumthekar, Priya
    Sloan, Andrew E.
    Kruchko, Carol
    Barnholtz-Sloan, Jill S.
    SCIENTIFIC REPORTS, 2019, 9 (1)
  • [39] Treatment results for non-small cell lung cancer patients presenting with brain metastases
    Shapiro, A.
    Gay, H. A.
    Hahn, S. S.
    Bogart, J. A.
    Shah, H.
    Chung, C. T.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2007, 69 (03): : S512 - S513
  • [40] Survival prediction with radiomics of patients with brain metastases of non-small cell lung cancer
    Prezado, Y.
    Dos Santos, M.
    Gonzalez, W.
    Jouvion, G.
    Guardiola, C.
    Heinrich, S.
    Labiod, D.
    Juchaux, M.
    Jourdain, L.
    Sebrie, C.
    Pouzoulet, F.
    RADIOTHERAPY AND ONCOLOGY, 2018, 127 : S298 - S299